Acupuncture Treatment to Reduce Burning Pain in Spinal Cord Injury
NCT ID: NCT00523016
Last Updated: 2013-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2007-09-30
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives of Study:
1. To determine the feasibility of conducting a real acupuncture vs. sham acupuncture trial in a multi-centre study using the Lyndhurst Central Neuropathic Pain Acupuncture Protocol (LCCNPAP). This will inform a larger study which will directly evaluate the effect of the LCCNPAP on pain and Quality of Life (QOL) in individuals with SCI.
2. To determine which outcome measures are most responsive and the amount of change that could be expected, with respect to pain and QOL, for the larger study.
3. To obtain preliminary data to determine subject numbers for future studies evaluating the effect of the acupuncture protocol.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Study of Clinical Utility of Acupuncture in Back Pain
NCT01231425
'Acupuncture Therapy' for Pain and Function Recovery in Spine Surgery Patients
NCT01304979
Acupuncture for Lumbar Spinal Stenosis
NCT06102798
Acupuncture for Lumbar Spinal Stenosis
NCT01987622
Stimulation of Acupuncture Points in Female Patients With Multiple Sclerosis and Neurogenic Bladder Dysfunction
NCT07183683
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A total of 13 treatments will be administered over a maximum of 4 consecutive weeks with an ideal treatment frequency as follows: 5 times per week during weeks one and two; and 3 times per week during week three.
Following all sessions, whether LCCNPAP group or sham, any adverse events such as nausea, fainting, bleeding etc., will be recorded on an adverse effects sheet for each subject. Baseline arterial blood pressure and heart rate will be monitored at four points during each treatment session for both groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Electroacupuncture
Subjects will receive Lyndhurst Central Neuropathic Pain Acupuncture Protocol (LCCNPAP) electroacupuncture protocol for 20 minutes per treatment session; a total of 13 treatments will be administered over 3-4 weeks.
Lyndhurst Central Neuropathic Pain Acupuncture Protocol (LCCNPAP)
LCCNPAP: acupuncture needle insertion at acupuncture points on the head that will be stimulated with electricity from a battery-operated Chinese acupuncture stimulation device for 20 minutes. A total of 13 treatments will be administered over 3-4 weeks.
Sham acupuncture
Subjects will receive simulated acupuncture that includes insertion of acupuncture needles on the head. During each treatment session, needles will be stimulated with electricity for 20 minutes. A total of 13 treatments will be administered over 3-4 weeks. This group will be offered the LCCNPAP treatment at the completion of study participation.
Sham acupuncture
Sham acupuncture: Simulated acupuncture that includes insertion of acupuncture needles on the head that will be stimulated with electricity from a battery-operated Chinese acupuncture stimulation device for 20 minutes. A total of 13 treatments will be administered over 3-4 weeks. This group will be offered the LCCNPAP treatment at the completion of study participation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lyndhurst Central Neuropathic Pain Acupuncture Protocol (LCCNPAP)
LCCNPAP: acupuncture needle insertion at acupuncture points on the head that will be stimulated with electricity from a battery-operated Chinese acupuncture stimulation device for 20 minutes. A total of 13 treatments will be administered over 3-4 weeks.
Sham acupuncture
Sham acupuncture: Simulated acupuncture that includes insertion of acupuncture needles on the head that will be stimulated with electricity from a battery-operated Chinese acupuncture stimulation device for 20 minutes. A total of 13 treatments will be administered over 3-4 weeks. This group will be offered the LCCNPAP treatment at the completion of study participation.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* over 18 years of age
* traumatic Spinal Cord Injury\* (SCI) onset as an adult. \*Traumatic SCI for the purposes of this study, is defined as: 'SCI due to sudden forceful impact on the spinal cord with or without bony injury'.This would include: falls, MVAs, hyperextension injuries, penetrating wounds (gunshot, knives), sports injuries, and exclude: tumours, vascular accidents (AVM), demyelinating conditions, infection, and iatrogenic causes.
* major symptom of burning pain below SCI level
* screened as positive for Central Neuropathic Pain by clinical assessment by Site Investigators which includes completing the LANSS Questionnaire
* English-speaking
* capable of giving informed consent
* on stable pain therapy (i.e. no changes in pain medications for 1 week)
Exclusion Criteria
* major psychiatric disorders
* scalp lacerations or infections
* hearing or language problems
* history of diabetes or disease that would affect peripheral nerve function
* pregnancy
* serious co-morbidities
* needle phobia
* having undergone Lyndhurst Centre Central Neuropathic Pain Acupuncture Protocol previously
* having had acupuncture in the last 30 days
* treatment involving use of electrical therapy modalities (i.e. Codetron or TENS) in the last 30 days
* seizure disorders, convulsions
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
University of British Columbia
OTHER
Toronto Rehabilitation Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Linda M. Rapson
Adjunct Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Linda M Rapson, MD
Role: PRINCIPAL_INVESTIGATOR
Toronto Rehabilitation Institute Lyndhurst Centre
Eva Widerström-Noga, PhD
Role: STUDY_DIRECTOR
University of Miami
Judith Hunter, PhD
Role: STUDY_DIRECTOR
University of Toronto
Judi Laprade, PhD
Role: STUDY_DIRECTOR
University of Toronto
John Clement, MD
Role: STUDY_DIRECTOR
Parkwood Hospital
Patrick Potter, MD
Role: STUDY_DIRECTOR
Western University, Canada
Nimmi Bharatwal, MD
Role: STUDY_DIRECTOR
University of Toronto
Andrei Krassioukov, MD
Role: STUDY_DIRECTOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
G. F. Strong Rehabilitation Centre
Vancouver, British Columbia, Canada
Parkwood Hospital
London, Ontario, Canada
Toronto Rehabilitation Institute Lyndhurst Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TRI REB # 07-045
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.